Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Levis

Showing results (41-50 of 92) with videos related to

Pageof 10
Sort By:
Blood|January 26, 2011
FLT3 ligand impedes the efficacy of FLT3 inhibitors in vitro and in vivoTakashi Sato, Xiaochuan Yang, Steven Knapper, et al.
Leukemia & Lymphoma|September 28, 2011
Risk assessment in human immunodeficiency virus-associated acute myeloid leukemiaMichael W Evans, Anthony D Sung, Ivana Gojo, et al.
British Journal of Haematology|August 10, 2007
Constitutive Fms-like tyrosine kinase 3 activation results in specific changes in gene expression in myeloid leukaemic cellsKyu-Tae Kim, Kristin Baird, Sean Davis, et al.
British Journal of Haematology|March 16, 2007
FLT3/ITD expression increases expansion, survival and entry into cell cycle of human haematopoietic stem/progenitor cellsLi Li, Obdulio Piloto, Kyu-Tae Kim, et al.
Signal Transduction and Targeted Therapy|May 24, 2021
FLT3 tyrosine kinase inhibitors synergize with BCL-2 inhibition to eliminate FLT3/ITD acute leukemia cells through BIM activationRuiqi Zhu, Li Li, Bao Nguyen, et al.
Blood|January 11, 2014
TTT-3002 is a novel FLT3 tyrosine kinase inhibitor with activity against FLT3-associated leukemias in vitro and in vivoHayley Ma, Bao Nguyen, Li Li, et al.
American Journal of Clinical Pathology|February 17, 2012
Clinical and pathologic features of secondary acute promyelocytic leukemiaAmy S Duffield, Joseph Aoki, Mark Levis, et al.
Blood|March 31, 2005
Internal tandem duplications of the FLT3 gene are present in leukemia stem cellsMark Levis, Kathleen M Murphy, Rosalyn Pham, et al.
The Journal of Molecular Diagnostics : JMD|April 23, 2003
Detection of FLT3 internal tandem duplication and D835 mutations by a multiplex polymerase chain reaction and capillary electrophoresis assayKathleen M Murphy, Mark Levis, Michael J Hafez, et al.
Blood|January 17, 2004
Single-agent CEP-701, a novel FLT3 inhibitor, shows biologic and clinical activity in patients with relapsed or refractory acute myeloid leukemiaB Douglas Smith, Mark Levis, Miloslav Beran, et al.
Pageof 10

Showing results (41-50 of 92) with videos related to

Sort By:
Pageof 10
Blood|January 26, 2011
FLT3 ligand impedes the efficacy of FLT3 inhibitors in vitro and in vivoTakashi Sato, Xiaochuan Yang, Steven Knapper, et al.
Leukemia & Lymphoma|September 28, 2011
Risk assessment in human immunodeficiency virus-associated acute myeloid leukemiaMichael W Evans, Anthony D Sung, Ivana Gojo, et al.
British Journal of Haematology|August 10, 2007
Constitutive Fms-like tyrosine kinase 3 activation results in specific changes in gene expression in myeloid leukaemic cellsKyu-Tae Kim, Kristin Baird, Sean Davis, et al.
British Journal of Haematology|March 16, 2007
FLT3/ITD expression increases expansion, survival and entry into cell cycle of human haematopoietic stem/progenitor cellsLi Li, Obdulio Piloto, Kyu-Tae Kim, et al.
Signal Transduction and Targeted Therapy|May 24, 2021
FLT3 tyrosine kinase inhibitors synergize with BCL-2 inhibition to eliminate FLT3/ITD acute leukemia cells through BIM activationRuiqi Zhu, Li Li, Bao Nguyen, et al.
Blood|January 11, 2014
TTT-3002 is a novel FLT3 tyrosine kinase inhibitor with activity against FLT3-associated leukemias in vitro and in vivoHayley Ma, Bao Nguyen, Li Li, et al.
American Journal of Clinical Pathology|February 17, 2012
Clinical and pathologic features of secondary acute promyelocytic leukemiaAmy S Duffield, Joseph Aoki, Mark Levis, et al.
Blood|March 31, 2005
Internal tandem duplications of the FLT3 gene are present in leukemia stem cellsMark Levis, Kathleen M Murphy, Rosalyn Pham, et al.
The Journal of Molecular Diagnostics : JMD|April 23, 2003
Detection of FLT3 internal tandem duplication and D835 mutations by a multiplex polymerase chain reaction and capillary electrophoresis assayKathleen M Murphy, Mark Levis, Michael J Hafez, et al.
Blood|January 17, 2004
Single-agent CEP-701, a novel FLT3 inhibitor, shows biologic and clinical activity in patients with relapsed or refractory acute myeloid leukemiaB Douglas Smith, Mark Levis, Miloslav Beran, et al.
Pageof 10